stabl
monoclon
cell
line
immort
human
b
cell
express
b
cell
receptor
bcr
cell
surfac
secret
antibodi
would
attract
tool
studi
variou
aspect
bcr
signal
also
gener
human
monoclon
antibodi
bcr
express
polyclon
immort
human
b
cell
would
facilit
select
cell
basi
bind
antigen
specif
bcr
product
antibodi
enabl
select
b
cell
clone
basi
function
activ
secret
antibodi
memori
b
cell
express
cell
surfac
bcr
secret
ig
cell
simultan
express
bcr
secret
antibodi
might
present
light
zone
germin
center
gc
cell
may
repres
plasmablast
readi
select
plasma
cell
compart
gc
consist
two
area
dark
light
zone
popul
centroblast
centrocyt
respect
antigenactiv
memori
b
cell
gc
undergo
extens
prolifer
accompani
somat
hypermut
shm
classswitch
recombin
csr
ig
gene
process
mediat
activ
induc
cytidin
deaminas
aid
light
zone
gc
b
cell
undergo
select
via
interact
follicular
dendrit
cell
receiv
help
follicular
helper
cell
ultim
develop
memori
antibodysecret
plasma
cell
select
light
zone
gc
b
cell
express
bclxl
member
anti
apoptot
protein
famili
like
protect
cell
death
matur
b
cell
cultur
vitro
condit
mimic
key
aspect
gc
reaction
activ
b
cell
ligand
l
presenc
cytokin
like
interleukin
il
b
cell
cultur
produc
littl
ig
addit
lead
differenti
plasma
cell
accompani
high
ig
secret
although
vitro
system
proven
use
studi
aspect
b
cell
differenti
igd
b
cell
switch
memori
b
cell
eventu
differenti
termin
differenti
plasma
cell
accompani
cell
cycl
arrest
preclud
gener
longterm
antigenspecif
bcr
posit
cell
line
recent
advanc
provid
insight
multipl
transcript
factor
includ
blymphocyteinduc
matur
protein
xboxbind
protein
bcell
lymphoma
bcl
control
develop
gc
b
cell
termin
arrest
antibodyproduc
plasma
cell
transcript
repressor
shown
prevent
plasma
cell
differenti
gc
b
cell
facilit
expans
b
cell
downregul
prevent
prematur
differenti
b
cell
plasma
cell
neg
regul
recent
report
signal
transduc
activ
transcript
stat
activ
small
subset
human
gc
b
cell
cell
express
rel
high
level
low
level
forc
express
constitut
activ
b
cell
induc
express
bclxl
provid
evid
direct
target
b
cell
regul
termin
differenti
facilit
vitro
expans
b
cell
sinc
ectop
express
b
cell
inhibit
termin
differenti
vitro
inhibit
facilit
vitro
expans
activ
b
cell
show
ectop
express
bclxl
synerg
increas
prolif
lifespan
b
cell
vitro
expand
cell
featur
gc
b
cell
express
function
bcr
secret
antibodi
provid
novel
power
tool
gener
human
bcrposit
antibodysecret
b
cell
line
hypothes
bclxl
express
gc
b
cell
control
synerg
increas
prolif
surviv
potenti
b
cell
vitro
test
hypothesi
isol
human
memori
b
cell
peripher
blood
introduc
bclxl
cell
retrovirusmedi
gene
transfer
transduc
cell
cultur
irradi
express
l
cell
cell
presenc
factor
produc
follicular
helper
cell
gc
strongli
induc
prolifer
b
cell
transduc
cell
visual
express
marker
gfp
bclxl
fig
cell
express
bclxl
rapidli
increas
frequenc
cultur
within
twoweek
period
fig
addit
cell
exhibit
clear
expans
advantag
compar
cell
express
bclxl
alon
fig
left
panel
cell
popul
sort
cultur
independ
transduc
cell
show
enhanc
expans
compar
bclxlonli
transduc
cell
fig
right
panel
normal
human
b
cell
rapidli
differenti
antibodyproduc
plasma
cell
cultur
cell
presenc
accompani
decreas
express
surfac
bcr
mhc
class
ii
increas
express
contrast
nontransduc
cell
cell
express
bclxl
cultur
cell
retain
bcr
express
fig
confirm
inhibit
b
cell
differenti
bclxl
introduc
b
cell
nonhuman
primat
mice
retrovirusmedi
gene
transfer
observ
rapid
expans
least
one
month
presenc
l
cell
supplementari
figur
similar
transduc
human
b
cell
indic
bclxl
allow
expans
b
cell
multipl
speci
posit
b
cell
expand
express
activ
marker
icosl
cytokin
receptor
cell
express
level
equival
tonsil
gc
cell
express
hladr
transduc
cell
consist
higher
compar
freshli
isol
tonsil
gc
cell
fig
may
due
activ
statu
increas
size
cell
transduc
cell
express
aicda
encod
enzym
aid
level
compar
express
freshli
isol
gc
b
cell
fig
shown
aid
function
cell
shm
ig
gene
expand
b
cell
induc
sinc
aid
express
peripher
blood
memori
cell
fig
plasma
cell
transduc
cell
show
express
typic
gc
cell
surfac
marker
result
indic
bclxl
express
combin
signal
confer
gclike
characterist
human
memori
b
cell
sinc
transduc
b
cell
express
high
level
bcr
cell
surfac
membran
examin
whether
antigen
bind
bcr
could
exploit
gener
antigenspecif
b
cell
clone
individu
immun
tetanu
toxin
produc
clostridium
tetani
harbor
memori
b
cell
specif
toxin
purifi
peripher
memori
b
cell
two
healthi
donor
transduc
bclxl
posit
cultur
cell
stain
phycoerythrin
pe
label
tetanu
toxoid
tt
fig
cell
bound
pelabel
tt
fac
sort
seed
limit
cell
number
cellwel
within
two
week
frequenc
ttspecif
b
cell
clone
igg
kappa
lambda
light
chain
posit
aros
expand
fig
fig
clone
cell
cultur
maintain
short
doubl
time
h
averag
six
week
fig
could
maintain
extend
period
time
remain
tt
specif
month
data
shown
examin
whether
bcr
function
cultur
igg
ttspecif
nonspecif
b
cell
line
absenc
cell
hour
rest
cell
stimul
tt
antigen
igg
f
ab
specif
antibodi
analyz
phosphoryl
p
extracellular
kinas
erk
within
second
addit
tt
perk
detect
ttspecif
cell
ttneg
cell
fig
indic
presenc
antigen
specif
function
bcrcoupl
signal
transduct
machineri
cell
perk
detect
cell
line
stimul
igg
f
ab
antibodi
fig
addit
tt
igg
f
ab
antibodi
b
cell
induc
rapid
shift
ratio
bound
versu
unbound
indic
tt
igg
f
ab
induc
flux
fig
result
demonstr
bcr
express
cell
surfac
transduc
memori
b
cell
signal
compet
use
expand
b
cell
transduc
bclxl
strong
induc
differenti
igsecret
cell
transduc
cell
inde
secret
ig
fig
averag
product
igg
transduc
cell
lower
plasma
cell
although
higher
memori
b
cell
supplementari
fig
analysi
igg
igm
level
produc
monoclon
cell
line
cultur
reveal
clone
produc
ig
igmproduc
clone
secret
five
six
time
ig
iggproduc
clone
fig
also
observ
cultur
nontransduc
memori
cell
although
cell
cultur
secret
antibodi
downregul
bcr
nontransduc
antibodysecret
plasma
cell
supplementari
fig
given
rel
high
amount
secret
antibodi
b
cell
examin
whether
could
select
antigenspecif
b
cell
basi
secret
specif
antibodi
chose
pathogen
respiratori
syncyti
viru
rsv
antigen
moieti
rsv
common
caus
bronchiol
pneumonia
among
infant
children
year
age
seriou
health
problem
elderli
peopl
transduc
memori
b
cell
healthi
donor
seed
cellswel
expand
cell
week
cultur
supernat
harvest
screen
presenc
rsvneutral
antibodi
microneutr
experi
cultur
cellswel
prevent
rsv
infect
cell
four
microcultur
highest
neutral
activ
subclon
limit
dilut
four
monoclon
cell
line
select
character
observ
median
half
maximum
inhibitori
concentr
viru
rang
ng
ng
ng
fig
comparison
three
four
ab
exhibit
significantli
lower
valu
compar
palivizumab
ng
human
fdaapprov
monoclon
antibodi
current
use
prophylaxi
infant
high
risk
addit
rsv
antibodi
effici
neutral
primari
rsv
isol
x
rsvx
fig
test
vivo
neutral
activ
prophylact
set
infect
cotton
rat
standard
model
test
rsv
infect
pathogen
primari
isol
rsvx
anim
inject
im
variou
quantiti
recombin
mg
palivizumab
mg
control
mg
one
day
intranas
inocul
rsvx
anim
sacrif
day
post
challeng
sinc
time
point
peak
lung
viru
titer
observ
rsvx
titer
lung
analyz
standard
cultur
assay
fig
palivizumab
complet
prevent
vivo
viral
replic
mg
show
efficaci
alreadi
dose
mg
partial
neutral
dose
mg
data
show
also
vivo
function
potent
reduc
rsv
replic
analysi
aicda
express
monoclon
cell
line
realtim
pcr
reveal
variabl
express
differ
clonal
cell
line
sever
clone
express
level
similar
gc
tonsil
b
cell
wherea
other
aicda
low
fig
determin
whether
aid
function
b
cell
clone
subclon
rsv
specif
monoclon
bcell
line
singl
cell
sort
analyz
vh
gene
presenc
mutat
sixti
three
percent
well
seed
show
robust
expans
suggest
express
aid
result
genet
instabl
lead
growth
arrest
cell
death
week
cultur
supernat
subclon
harvest
rna
cell
isol
subsequ
cdna
gener
vh
region
sequenc
sequenc
analysi
reveal
total
vh
mutat
uniqu
mutat
result
estim
mutat
rate
mutat
per
bp
per
cell
divis
lower
end
estim
aidmedi
mutat
rate
vivo
vh
gene
individu
subclon
show
variabl
number
mutat
subclon
harbor
one
three
mutat
vh
region
silent
mutat
harbor
three
vh
mutat
twenti
four
percent
clone
vh
mutat
fig
vh
gene
contain
aid
mutat
hotspot
rgywwrci
account
total
mutat
mutat
predominantli
observ
cdr
region
fig
supernat
major
subclon
bound
rsvinfect
cell
similar
recombin
clone
bound
either
less
better
fig
differ
bind
activ
associ
mutat
vh
region
applic
would
desir
inhibit
aid
prevent
accumul
mutat
ig
gene
transduc
b
cell
clone
achiev
took
advantag
fact
aid
regul
basic
helix
loop
helix
transcript
factor
overexpress
helix
loop
helix
factor
inhibitor
dna
bind
id
known
form
transcript
inact
complex
therebi
inhibit
aid
express
shown
figur
overexpress
strongli
reduc
aicda
level
cell
line
without
influenc
prolifer
cell
data
shown
thu
modul
level
provid
method
prevent
aid
induc
mutat
transduc
b
cell
describ
effici
rapid
method
gener
antigenspecif
bcr
posit
b
cell
line
retrovir
introduct
gcexpress
gene
bclxl
convert
peripher
blood
memori
cell
gclike
b
cell
maintain
prolong
period
cultur
bclxl
involv
gc
respons
requir
gc
format
bclxl
import
antiapoptot
factor
gc
transduc
cell
express
marker
human
gc
b
cell
includ
aid
icosl
later
shown
import
gc
format
evid
data
doubletransduc
cell
resembl
gc
b
cell
respect
surfac
marker
aicda
express
whether
classifi
centroblast
centrocyt
less
clear
suggest
centrocytelik
natur
perhap
repres
small
subset
centrocyt
sinc
transduc
b
cell
express
function
bcr
long
held
characterist
light
zone
centrocyt
bcr
particip
select
follicular
dendrit
cell
occur
light
zone
moreov
expans
b
cell
depend
upon
signal
dark
zone
mostli
devoid
cell
activ
cell
present
light
zone
addit
nuclear
transloc
nfkb
induc
signal
observ
b
cell
light
zone
express
aicda
cell
line
rais
question
whether
aid
function
although
aid
express
clone
deriv
transduc
peripher
blood
memori
cell
level
variabl
moreov
observ
isotyp
switch
cell
time
indic
aicda
express
insuffici
drive
process
least
time
frame
cultur
condit
appli
contrast
observ
occurr
somat
hypermut
rel
low
frequenc
subclon
one
rsvspecif
b
cell
clone
screen
mab
contain
cultur
supernat
subclon
rsv
infect
cell
demonstr
variat
bind
capac
result
suggest
addit
vh
gene
mutat
subclon
result
chang
antigenbind
affin
data
rais
possibl
ongo
aidmedi
mutat
activ
b
cell
clone
use
select
higher
lower
affin
clone
obviat
need
deliber
molecular
engin
relev
ig
gene
conceiv
case
mutat
ig
gene
establish
clone
b
cell
line
need
avoid
show
follow
introduct
b
cell
alreadi
overexpress
bclxl
aicda
level
strongli
reduc
consist
find
publish
sayeg
et
al
thu
overexpress
prevent
ongo
aidmedi
mutat
activ
frozen
vhvl
repertoir
requir
despit
express
aicda
bclxltransduc
igg
igm
iga
memori
b
cell
observ
csr
cell
data
shown
might
relat
differ
requir
aidmedi
shm
csr
previous
show
abl
elicit
ig
secret
polyclon
b
cell
combin
stabl
bcr
express
allow
select
antigen
specif
b
cell
bind
fluorescentlabel
antigen
ig
secret
allow
function
screen
secret
ig
method
provid
tool
rapid
isol
potenti
therapeut
antibodi
inde
abl
gener
uniqu
rsv
neutral
antibodi
within
month
direct
function
screen
follow
immort
b
cell
obtain
rsvexpos
individu
recent
anoth
method
gener
monoclon
antibodi
human
b
cell
describ
base
epsteinbarr
viru
ebv
transform
b
cell
activ
toll
like
antagonist
method
describ
traggiai
et
al
util
human
b
cell
expos
individu
select
monoclon
antibodi
varieti
microb
without
need
recent
vaccin
donor
howev
contrast
b
cell
transform
ebv
b
cell
line
obtain
genet
program
stabli
express
high
level
signalingcompet
membranebound
bcr
high
level
cell
surfac
bcr
facilit
isol
b
cell
basi
antigen
bind
greatli
increas
frequenc
antigen
specif
cell
abrog
need
extens
subclon
wherea
gener
antigen
specif
clone
use
ebv
method
take
month
genet
program
approach
reduc
month
fact
rare
b
cell
easili
clone
compar
method
favor
recent
describ
singl
cell
clone
approach
use
isol
influenzaspecif
antibodi
studi
ig
dna
isol
day
influenza
vaccin
popul
b
cell
contain
rel
high
frequenc
sever
influenza
virusspecif
b
cell
feasibl
techniqu
depend
rel
high
frequenc
antigenspecif
b
cell
obtain
vaccin
recent
exposur
microb
discuss
express
aid
genet
modifi
clone
may
util
select
antibodi
higher
affin
provid
advantag
compar
ebv
transform
singl
cell
pcr
method
platform
gener
human
monoclon
antibodi
anoth
advantag
method
describ
use
obtain
stabl
line
b
cell
speci
human
demonstr
b
cell
mice
nonhuman
primat
prolifer
least
one
month
presenc
also
gener
seri
clone
line
mous
b
cell
result
shown
therefor
feasibl
assum
method
allow
expans
antigenspecif
b
cell
multipl
speci
includ
rabbit
goat
line
obtain
use
ebv
capabl
transform
b
cell
varieti
monkey
speci
chimpanze
marmoset
squirrel
owl
cebu
monkey
monoclon
cell
line
gener
technolog
use
gener
monoclon
antibodi
also
allow
detail
mechanist
studi
bcrmediat
signal
transduct
induc
specif
antigen
may
use
studi
signal
bcr
variant
differ
affin
antigen
furthermor
cell
line
use
tool
studi
effect
varieti
extern
signal
like
antigen
cytokin
function
aid
induct
shm
obtain
b
cell
peripher
blood
sanquin
ficol
separ
mac
microbead
miltenyi
biotech
subsequ
sort
cell
igg
memori
cell
igm
memori
cell
facsaria
becton
dickinson
obtain
tonsil
b
cell
routin
tonsillectomi
perform
depart
otolaryngolog
academ
medic
center
amsterdam
netherland
use
tissu
approv
medic
ethic
committe
institut
conting
inform
consent
maintain
b
cell
cell
imdm
gibco
cultur
medium
contain
fb
hyclon
penicillinstreptomycin
roch
supplement
recombin
mous
ng
r
system
cocultur
mous
l
cell
fibroblast
stabli
express
cell
cell
use
r
ng
u
test
cell
routin
pcr
presenc
mycoplasma
ebv
data
shown
retrovir
construct
describ
previous
clone
human
bclxl
cdna
lzr
retrovir
vector
perform
transfect
product
amphotrop
ecotrop
viru
phoenix
packag
cell
describ
cotransduc
memori
b
cell
retrovirus
activ
cell
presenc
h
centrifug
cell
viru
room
temperatur
min
g
rpm
analyz
stain
cell
lsrii
bd
process
flow
cytometri
data
flowjo
softwar
tree
star
antibodi
describ
onlin
supplementari
method
section
carri
quantit
rtpcr
biorad
icycl
use
method
calcul
rel
mrna
express
level
normal
actin
primer
aicda
encod
aid
describ
coat
plate
either
antihuman
igg
igm
fcfragment
jackson
immunoresearch
laboratori
pb
h
wash
elisa
wash
buffer
pb
milk
pb
use
block
agent
ad
serial
dilut
cell
cultur
supernat
hrpconjug
detect
ab
dilut
hrpconjug
igg
antibodi
jackson
dilut
hrpconjug
igm
antibodi
jackson
use
tmb
substrat
solut
biosourc
develop
elisa
lyse
cell
triton
lysi
buffer
supplement
halt
proteas
inhibitor
roch
separ
equal
amount
protein
sdspage
transfer
nitrocellulos
probe
use
antibodi
cell
signal
technolog
antibodi
santa
cruz
use
enhanc
chemiluminesc
pierc
biotechnolog
xray
film
hyperfilm
ge
healthcar
life
scienc
detect
cultur
transduc
b
cell
two
day
without
cell
presenc
subsequ
load
cell
sigmaaldrich
fluoresc
ratio
emiss
nm
measur
flow
cytometri
facsvantag
se
bd
seed
cell
flat
bottom
well
plate
costar
next
day
preincub
rsv
x
viru
mix
b
cell
cultur
supernat
min
ad
triplic
cell
h
day
fix
cell
aceton
stain
polyclon
rsvhrp
antibodi
biodesign
detect
visual
rsv
plaqu
light
microscopi
plaqu
count
isol
total
rna
mini
kit
qiagen
gener
cdna
perform
pcr
clone
heavi
light
chain
variabl
region
ta
clone
vector
invitrogen
rule
revers
transcriptas
dna
polymeras
induc
mutat
perform
sever
independ
clone
experi
produc
recombin
mab
clone
heavi
light
variabl
region
frame
human
kappa
constant
region
invitrogen
base
vector
transient
transfect
cell
purifi
recombin
cultur
supernat
protein
week
old
cotton
rat
sigmodon
hispidu
charl
river
anesthet
isofluran
bled
given
ml
purifi
mab
per
gram
bodi
weight
bw
intramuscular
im
inject
dose
palivizumab
mg
bw
control
antibodi
twentyfour
hour
later
anim
anesthet
challeng
intranas
instil
rsvx
five
day
later
anim
sacrif
lung
harvest
lung
viru
titer
determin
lowest
limit
detect
anim
experi
committe
netherland
vaccin
institut
approv
procedur
involv
cotton
rat
